ADMET/PK optimization
The company applies ADMET/PK optimization to revive abandoned preclinical drug assets.
Source: LinkedIn company description · Retrieved October 13, 2026
VIRTUALMAN focuses on reviving abandoned preclinical drug assets.
Its model re-optimizes high-potential assets abandoned due to ADMET/PK issues and transforms them into licensable drug candidates. The model has been validated through collaboration with the Development Center for Biotechnology.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company applies ADMET/PK optimization to revive abandoned preclinical drug assets.
Source: LinkedIn company description · Retrieved October 13, 2026
Lead compound generation is part of the company's approach to reviving abandoned preclinical drug assets.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated October 7, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.